|
|
|
|
|
by walterbell
1757 days ago
|
|
Thanks, this is helpful, will review. In theory, those opposed to early treatments could publish a competing analysis of studies on early treatments. Maybe that has already been done? On some contested topics, there's almost a need for rules of evidence, so there's an agreed upon list of papers/data for discussion. Then different stakeholders/teams can debate on their (likely biased) interpretations of a pool of evidence that is clearly bounded at any point in time, but expanding as new data/studies become available. |
|
I was curious so I ran Whois queries on three sites: c19early.com which you linked, and ivmmeta.com and c19ivermectin.com. They all seem to be hosted through google sites, and use the same DNS privacy service. I don’t know if google sites by default uses this service or something, but just looking at the similarity of the sites I am wary.
[0]: https://blogs.sciencemag.org/pipeline/archives/2021/06/07/iv...